These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 22215851)
1. Next steps in clinical trial redesign. Nicholas J J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851 [No Abstract] [Full Text] [Related]
2. Overhaul of NCI Clinical Trial System Still in Progress. Nicholas J J Natl Cancer Inst; 2013 Aug; 105(15):1067-8. PubMed ID: 23884052 [No Abstract] [Full Text] [Related]
3. American Society of Clinical Oncology Developing First Clinical Trial. Brower V J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625 [No Abstract] [Full Text] [Related]
4. Shaking up cancer clinical trials: an interview with John Mendelsohn, M.D., by Joanne Nicholas. Mendelsohn J J Natl Cancer Inst; 2010 Aug; 102(16):1219-21. PubMed ID: 20693458 [No Abstract] [Full Text] [Related]
5. Researchers push back against overhauling clinical trials. Jenks S J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25122733 [No Abstract] [Full Text] [Related]
6. Proposed new clinical trial system at NCI gets mixed reviews. Nicholas J J Natl Cancer Inst; 2011 Feb; 103(4):292-5. PubMed ID: 21303997 [No Abstract] [Full Text] [Related]
7. Cancer clinical trials--a chronic but curable crisis. Young RC N Engl J Med; 2010 Jul; 363(4):306-9. PubMed ID: 20554976 [No Abstract] [Full Text] [Related]
9. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network. Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062 [TBL] [Abstract][Full Text] [Related]
10. The structure of clinical translation: efficiency, information, and ethics. Kimmelman J; London AJ Hastings Cent Rep; 2015; 45(2):27-39. PubMed ID: 25628068 [TBL] [Abstract][Full Text] [Related]
11. What do research ethics committees say about applications to do cancer trials? Dixon-Woods M; Angell E; Tarrant C; Thomas A Lancet Oncol; 2008 Aug; 9(8):700-1. PubMed ID: 18672207 [No Abstract] [Full Text] [Related]
12. NCI-MATCH launch highlights new trial design in precision-medicine era. McNeil C J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446 [No Abstract] [Full Text] [Related]
13. How should adverse events be reported in US clinical trials?: ethical considerations. Shamoo AE; Katzel LI Clin Pharmacol Ther; 2008 Aug; 84(2):275-8. PubMed ID: 18305454 [TBL] [Abstract][Full Text] [Related]
14. IOM advises FDA on ethics in postmarket safety trials. Kuehn BM JAMA; 2010 Aug; 304(6):627. PubMed ID: 20699450 [No Abstract] [Full Text] [Related]
15. Learning from exceptional drug responders. Mullard A Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081 [No Abstract] [Full Text] [Related]
16. Trial watch: Lung cancer trial aims to bolster personalized medicine. Harrison C Nat Rev Drug Discov; 2014 Jun; 13(6):407. PubMed ID: 24875087 [No Abstract] [Full Text] [Related]
17. Drug companies cut costs with foreign clinical trials. Rai S N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516 [No Abstract] [Full Text] [Related]
18. Improving the conduct of cancer trials in the USA. Lancet; 2010 Apr; 375(9724):1408. PubMed ID: 20417838 [No Abstract] [Full Text] [Related]
19. IOM report calls for a more streamlined, faster cancer cooperative trials program. Kuehn BM JAMA; 2010 Jun; 303(21):2126-7. PubMed ID: 20516407 [No Abstract] [Full Text] [Related]
20. Leaders worry that U.S. is losing edge on cancer clinical trials. Twombly R J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275 [No Abstract] [Full Text] [Related] [Next] [New Search]